RIMS Software: Requirements and Selection Worksheet

The first useful buying question is specific: can an authorized person retrieve an application's current status, its supporting authority letter, and every open obligation with an owner or an explicit ownership exception? If the answer depends on several spreadsheets and an individual remembering which email matters, document that dependency before choosing software.

This guide provides a reusable requirements register and a complete fictional selection exercise. It addresses what your RIMS must do. The RIM software comparison covers named products; the RIM implementation guide covers migration and release planning. Keeping those decisions separate makes proposals easier to compare.

Define the RIMS job before choosing a platform

RIM means regulatory information management; RIMS commonly refers to the supporting system or software. Vendors use these labels for different combinations of structured data, documents and workflow. A category name does not establish that a proposed module maintains registrations, publishes submissions or manages an authority response. For an introduction to the terminology, see what RIMS means.

Start by identifying the business question, the record that answers it and the source supporting that record. Separate product identity from application identity and market authorization. One product can have several applications and registrations; an approval in one market cannot establish its status elsewhere.

As a concrete product example, Veeva describes registrations, authority correspondence, commitments and changes within its Registrations offering. That illustrates why a registration record needs relationships to other work; it is not a universal object model every supplier must copy. Source: Veeva Registrations.

Use this scope statement before collecting feature requests:

Organization size informs staffing and administration, but it should not decide the architecture by itself. A small sponsor can have difficult licensing and partner-access requirements. A large organization may need a bounded workflow for one portfolio. Record the actual users, volumes, interfaces and responsibilities rather than assuming “small” means basic or “enterprise” means unlimited.

Use requirements instead of Basic, Standard and Enterprise labels

There is no universal RIMS tier model that makes Basic on-premise, Standard integrated and Enterprise compliant. Those labels describe individual commercial packages when a vendor defines them. Ask for the named product, edition, modules, deployment arrangement and offered release, then assess the operation you need.

Treat regulatory intelligence, label management, publishing and portal connections as separate scope decisions. They can matter greatly, but none should enter the first purchase simply because a generic feature list calls it essential. The regulatory submissions software guide and publishing guide help distinguish submission tracking from package production.

Copy this requirements register

The following conditions are proposed procurement criteria, not a regulator-issued checklist. For each row, add Mandatory / Preferred / Outside scope, the exact configuration and the result record described below. Replace the examples with your intended use before sending them to suppliers.

These rows expose distinct failures. R-03 can fail because the workflow permits silent unassigned work, while R-04 can fail because a report hides it. Do not merge them into one “commitment management” score. Likewise, readable document exports and preserved record relationships may need separate subrequirements once the data inventory is known.

Add portfolio-specific rows where required: device identifiers, registration renewal rules, product-data outputs, specific languages, partner access or authority interfaces. Name the exact destination, transaction and source revision for an interface. “Supports APIs” says little about whether your planned transaction exists or what happens when it fails.

Record a result that another reviewer can inspect

Use one result record per requirement and configuration:

Pass means the specified condition was demonstrated in the evaluated scope. Fail means evidence contradicts it. Unknown means the evidence is missing or inconclusive. Not applicable requires a recorded scope reason; it is not a substitute for an absent capability. If the supplier confirms that a required current capability is unavailable, record Fail. If current availability has not been established, record Unknown. A roadmap promise does not make either result Pass; assess a future contractual delivery against a separately defined requirement.

First apply mandatory gates. Only then compare preferences such as interface convenience, reporting flexibility and administrative effort. If you use weighted preferences, choose weights with the actual decision-makers. A high usability score should not cancel a failed access requirement.

Worked example: a sponsor selecting an obligation workflow

The following sponsor, authorities, records, results and deadlines are entirely fictional. This is a reproducible editorial exercise, not a reported customer implementation or software test. Copy the inputs into a sandbox or use them in a supplier walkthrough; retain the actual outputs separately from the illustrative results below.

Example Sponsor owns one medicinal product with two applications. It retains its controlled document repository and external publisher. Its first purchase must maintain application/registration state and a complete view of open response obligations. Automated intelligence monitoring is outside this first release.

Source packet

Use these two application rows. The shared product is intentional; applications and authorities remain distinct.

These are the complete fictional document snippets needed for the task:

“

DOC-01, revision 1; September 28, 2026; Alder Authority; APP-A. Authorization AUTH-A-10 is granted for Product PX-10 in Alder. This decision applies to APP-A only.

“

DOC-02, revision 1; September 29, 2026; Birch Authority; APP-B. Receipt of the Product PX-10 application is acknowledged. Review is ongoing. This letter does not authorize marketing.

“

DOC-03, revision 1; October 1, 2026; Alder Authority; APP-A. Provide the revised manufacturing-site summary by November 18, 2026. Reference this request in the response.

“

DOC-04, revision 1; October 2, 2026; Example Sponsor internal planning note; APP-A. Working target for the manufacturing-site summary: November 4, 2026. An accountable response owner has not yet been appointed.

The source obligation row is OB-01: application APP-A; source DOC-03 revision 1; action “Provide revised manufacturing-site summary”; status Open; authority deadline November 18, 2026; internal target November 4, 2026; accountable owner blank. There are no other obligations in this packet. DOC-02 creates no explicit response obligation.

Agree these sandbox permissions: Global-RA can view both applications; Alder-RA can view APP-A only. Keep a separate authorized administrator account for setup. Do not use its broad access as evidence that the restricted account behaves correctly.

Required output before assigning an owner

The application view should show APP-A approved using DOC-01, and APP-B under review using DOC-02. DOC-03 belongs to APP-A even though APP-B shares the product. A deliberate attempt to associate it with APP-B must expose or prevent that incorrect association under the agreed review process.

The open-obligation report must contain one row, OB-01, with a visible missing-owner exception. It must keep the November 18 authority deadline separate from the November 4 internal target. A report with zero rows is not evidence that all commitments are fulfilled: it has omitted unresolved work.

Now add a controlled sponsor decision: ASSIGN-01, October 6, 2026, approved by the regulatory operations lead: assign OB-01 to role RA-Manufacturing; preserve both existing dates. The resulting report still contains one open obligation, now with RA-Manufacturing as owner. Keep the previous blank-owner state and assignment evidence available. Assignment does not mean the response was completed or accepted.

Compare two fictional configurations

For illustration, assume the evaluation produced the following evidence records. These results describe invented configurations, not real suppliers. Other requirements remain untested unless stated.

Configuration A fails mandatory requirements. Configuration B is a candidate for a further pilot, but it has not passed selection: identity/status checks, restricted access, portability and other mandatory rows still need evidence. The defensible decision is to continue a bounded evaluation, not to award the contract because B passed more demonstrated rows.

Assign A's reporting failure to its configuration owner and request a retest that includes the still-unassigned obligation. Assign B's missing access evidence to the system owner. The regulatory operations lead closes R-03/R-04 only after inspecting the corrected outputs; the system owner closes R-06 only after positive and negative account checks. Neither a promised fix nor a screenshot from an administrator closes the exception.

Specify what stays outside the RIMS

Use the sponsor's scope to make handoffs explicit. Its controlled repository owns approved document versions. Its RIMS owns application and obligation records. Its publisher owns package production. Each handoff needs stable identifiers and a receiving owner, even if all three functions are eventually supplied by one vendor.

For R-08, send a fictional manifest containing application=APP-A, submission=SUB-A-01, document=DOC-03, revision=1. The publishing partner returns receipt PUB-ACK-01 for SUB-A-01. Import it twice in the sandbox. The expected result is one logical receipt linked to SUB-A-01, with the repeat handled visibly rather than creating a second submission. Keep OB-01 open: a publishing receipt does not establish that the authority accepted its response.

If the publishing partner offers only a manual handoff, record the manual step and its reviewer. Automation is not a prerequisite for a defensible process; an unspecified handoff is the problem. The services versus software comparison helps allocate those responsibilities. For the package itself, distinguish the eCTD format from the RIMS status record.

Quality events need the same boundary. A QMS can own the change investigation while regulatory staff decide its implications for registrations. The QMS versus RIM guide, software comparison and combined-platform guide address when those processes share a platform and when they remain separate.

Assess assurance for the actual records and intended use

Replace “Is the Enterprise tier Part 11 validated?” with “Which records and signatures are in scope, which requirements apply, and what evidence supports the configured intended use?” Part 11's scope is tied to electronic records and signatures under applicable FDA requirements; it is not determined by a software package name. Where applicable, its closed-system provisions address controls including validation, record copies, retrieval, authorized access and audit trails. Source: 21 CFR Part 11, §§11.1 and 11.10.

FDA's final Scope and Application guidance explains its narrower interpretation, specified enforcement discretion and continued enforcement of predicate-rule requirements. It recommends documented scope decisions and a justified, risk-based approach to validation. Read that guidance with the current applicable rules rather than treating every administrative RIMS record as identically regulated. Source: FDA Part 11 guidance, sections III.B–C.

For R-09, the quality owner should identify the assessment, configuration evidence, procedures and supplier artifacts needed before release. A vendor test package can contribute evidence; the purchase alone does not establish your own workflow's suitability. Record who assesses changes after upgrades, who trains users and who approves the intended use. Keep this requirement distinct from a security certification, an uptime commitment or a successful functional demo.

Make migration evidence part of the proposal

Before asking for a go-live date, provide a small source inventory: record classes, stable identifiers, documents, relationship keys, history, access restrictions and known exceptions. Ask the supplier to identify transformations and customer decisions needed. Do not treat ambiguous status values or missing owners as cleanup the software will automatically solve.

Product/reference records can be prerequisites for dependent application data. Veeva's published migration guidance makes that dependency explicit for its own model; use your selected platform's model when planning the actual load. Source: Veeva RIM migration guidance.

For this sponsor, acceptance includes two distinct applications, their correct supporting documents, one open obligation, preserved dates and an inspectable ownership exception or approved assignment. A record count of two applications and one obligation is necessary but insufficient: the relationships and meanings must also survive.

Request an export early enough to inspect whether required history and source references are present. Agree how excluded historical material remains accessible. Use the implementation worksheet for migration rehearsals, final-change capture and release decisions instead of assuming a universal sequence of months or a fixed percentage of project time for testing.

Build a commercial decision from the accepted scope

Ask each supplier to quote the same users, records, environments and interfaces. Record the pricing unit—named user, concurrent user, product, submission, organization or another basis—and the treatment of affiliates and external partners. Separate recurring licenses from configuration, migration, assurance support, training, storage, API usage, support and exit assistance.

For every unpriced item record the question, owner and response date. Missing pricing is Unknown, not zero. Include internal work: source cleanup, process decisions, review and administration remain costs even when they do not appear on the supplier invoice. The pharma vendor selection framework provides broader commercial diligence.

A business case should use your own measured baseline. As an arithmetic illustration only, twelve monthly reports taking 90 minutes each consume 18 hours. A measured pilot result of 45 minutes per report would imply 9 hours, releasing 9 hours of monthly capacity under the same workload. It would not automatically create cash savings, eliminate review or establish a 50% improvement in unrelated regulatory work. Keep the assumed pilot figure separate from an actual measured result.

Finish with a decision record: selected scope, retained systems, mandatory Pass results, unresolved Fail/Unknown items, priced assumptions, accountable approvers and next evidence deadline. That is the usable output of requirements work. A long feature checklist without those decisions is not ready to become a contract.

If your immediate need is document preparation rather than registration management, discuss that narrower workflow with Assyro. Assyro's current FDA eCTD v4 and document capabilities are adjacent to the full RIMS requirements here; global registration management and IDMP functionality are not established. eCTD v3.2.2 is unsupported, and EMA remains roadmap. Keep any preparation purchase scoped to demonstrated authority, format and handoff requirements.